Asenapine-impurities | Pharmaffiliates

asenapine

Asenapine has been approved by the FDA for the acute treatment of adults with schizophrenia and acute treatment of manic or mixed episodes associated with bipolar I disorder with or without psychotic features in adults.. Reference standards of Asenapine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => Asenapine Maleate (IPRS/18/14)-from IPC
    [catalogue_number] => PA IPIPRS 18 14
    [category_ids] => ,151,
    [chemical_name] => 
    [weight] => NA
    [form] => 
    [cas] => NA
    [pslug] => asenapine-maleate-iprs-18-14-paipiprs1814
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA IPIPRS 18 14

Asenapine Maleate (IPRS/18/14)-from IPC


  • Catalogue No.:PA IPIPRS 18 14

  • CAS :

    NA

  • Molecular Formula :

  • Molecular Weight : NA